Man Group
SGMT icon

Man Group’s Sagimet Biosciences SGMT Stock Holding History

Man Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
53,777
+18,171
+51% +$101K ﹤0.01% 2227
2025
Q4 		$211K Sell
35,606
-11,340
-24% -$81.5K ﹤0.01% 2114
2025
Q3 		$322K Buy
+46,946
New +$381K ﹤0.01% 1978
2025
Q1 		– Sell
-17,322
Closed -$77.9K – 2346
2024
Q4 		$77.9K Buy
17,322
+992
+6% +$5.03K ﹤0.01% 1935
2024
Q3 		$45.2K Buy
+16,330
New +$50.3K ﹤0.01% 1923

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Man Group's SGMT Position: Q1 2026 in Review

Man Group increased its Sagimet Biosciences (SGMT) stake by 51% in Q1 2026, buying an estimated $101K and bringing the position to 53,777 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Man Group first reported a position in SGMT in Q3 2024 and has held it in 5 quarters since. The position peaked at $322K in Q3 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Man Group held 53,777 shares of Sagimet Biosciences worth $281K as of Q1 2026.
  • Man Group bought 18,171 Sagimet Biosciences shares in Q1 2026, an estimated $101K.
  • Sagimet Biosciences made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2227 holding.
  • Man Group first reported a position in Sagimet Biosciences in Q3 2024 and has held it in 5 quarters since.
  • Man Group's Sagimet Biosciences position peaked at $322K in Q3 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.